Page last updated: 2024-09-03

nnc 112 and Basal Ganglia Diseases

nnc 112 has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gerlach, J; Jensen, G; Nicholson, K; Peacock, L	1

Other Studies

1 other study(ies) available for nnc 112 and Basal Ganglia Diseases

Article	Year
Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys. European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:5 Topics: Animals; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Raclopride; Receptors, Dopamine D1; Time Factors	1999

Article

Year

Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys.

European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:5

Topics: Animals; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Raclopride; Receptors, Dopamine D1; Time Factors

1999